Dr Reddy's Laboratories - 23 Year Stock Price History | RDY

Historical daily share price chart and data for Dr Reddy's Laboratories since 2001 adjusted for splits and dividends. The latest closing stock price for Dr Reddy's Laboratories as of October 31, 2024 is 73.90.
  • The all-time high Dr Reddy's Laboratories stock closing price was 84.21 on August 21, 2024.
  • The Dr Reddy's Laboratories 52-week high stock price is 84.46, which is 14.3% above the current share price.
  • The Dr Reddy's Laboratories 52-week low stock price is 64.36, which is 12.9% below the current share price.
  • The average Dr Reddy's Laboratories stock price for the last 52 weeks is 74.19.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Dr Reddy's Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 75.1250 70.4116 84.2100 66.9621 73.9000 6.84%
2023 61.1625 51.0662 72.3401 50.9478 69.1689 35.40%
2022 53.6210 63.9427 63.9427 47.3029 51.0860 -20.30%
2021 64.3357 69.2133 73.1686 56.3463 64.0995 -7.48%
2020 53.2858 39.0792 70.3697 33.5558 69.2813 76.80%
2019 37.0374 36.0302 41.0075 33.6234 39.1854 8.38%
2018 32.2402 36.2108 37.5893 27.0844 36.1549 1.25%
2017 36.8557 42.8752 44.0641 28.6245 35.7070 -16.42%
2016 43.4782 42.8354 51.2068 38.6785 42.7242 -1.64%
2015 52.7088 46.7691 63.6103 40.8649 43.4359 -7.75%
2014 43.1022 37.3688 54.4971 35.8573 47.0864 23.76%
2013 33.9188 31.4812 38.1940 29.4923 38.0457 24.12%
2012 29.0978 27.5392 32.0240 25.0365 30.6525 14.03%
2011 30.5315 33.2308 34.9311 26.5527 26.8816 -18.30%
2010 27.2701 21.9773 37.1743 20.6170 32.9014 53.85%
2009 13.5524 8.9493 23.0815 6.4951 21.3855 148.96%
2008 11.6086 15.9206 15.9206 6.6003 8.5900 -45.69%
2007 14.1771 15.6767 16.0924 12.5673 15.8161 0.33%
2006 13.2039 9.4045 16.4449 9.4045 15.7633 69.17%
2005 7.7954 8.4522 9.4261 6.4806 9.3182 9.63%
2004 8.7279 13.7150 14.0600 6.4635 8.4994 -36.95%
2003 9.6961 8.3349 13.6894 7.5039 13.4807 64.50%
2002 8.0922 8.1171 10.0618 5.8336 8.1950 2.29%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $12.399B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.590B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00